TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›BMA
BMA logo

BMA

Macro Bank Inc.

Next earnings Aug 25, 2026 · consensus $215.15 EPS, $1.50T rev

Avoid
$90.24
▼ -2.44%
$90.24▲ +34.80%
over 1Y
L $37.48H $101.71
Today-2.4%
1W-0.1%
1M+1.4%
3M+18.7%
YTD+5.0%
1Y+34.8%
OverviewValuationQualityFilings
Rating
Avoid
Quality
B+
Valuation
Fair value
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy

Argentine bank files only foreign-form 6-Ks; SEC XBRL gives no income, capital or asset data to underwrite a call.

Shares outstanding 639M · FY2024

Banco Macro is one of Argentina's largest private banks, listed in the US as an ADR that reports via foreign-private-issuer 6-K filings rather than the standardized 10-K/10-Q XBRL this analysis relies on. As a result, the only fundamental figure available in the SEC data is shares outstanding of 639M, unchanged year-over-year. There is no revenue, net income, net interest margin, loan book, deposit, capital-ratio or asset-quality figure — none of the metrics that matter for assessing a bank.

For a financial institution, the absence of capital adequacy, asset quality, profitability and funding data is disqualifying for a grounded view. A price of $101.68 cannot be related to earnings or book value because neither is available here, so no valuation or quality judgment is possible from the provided figures. The methodology requires lowering conviction sharply when data is too thin to support a view; here the relevant data is absent.

Is BMA a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

No income data filed.

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$5.77B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-232026-06-24open ↗6-KPeriod ending 2026-06-172026-06-17open ↗6-KPeriod ending 2026-06-042026-06-04open ↗6-KPeriod ending 2026-05-272026-05-27open ↗6-KPeriod ending 2026-05-272026-05-27open ↗6-KPeriod ending 2026-05-202026-05-20open ↗6-KPeriod ending 2026-05-062026-05-06open ↗6-KPeriod ending 2026-04-302026-05-01open ↗20-FPeriod ending 2025-12-312026-04-20open ↗6-KPeriod ending 2026-04-092026-04-10open ↗6-KPeriod ending 2026-04-092026-04-09open ↗6-KPeriod ending 2026-04-082026-04-08open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
MomentumB+
37.4852-week101.70
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is Macro Bank Inc. (BMA) a buy?
BMA currently carries a Avoid rating with 2/5 conviction, derived from its latest SEC filings. Argentine bank files only foreign-form 6-Ks; SEC XBRL gives no income, capital or asset data to underwrite a call.
What is Macro Bank Inc.'s quality score?
BMA scores 75.06084395021725/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001347426, latest 6-K filed 2026-06-24) · EODHD · Proprietary analysis · as of 6/21/2026, 8:55:26 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:55 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score75 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2